Whole body search
Conditions
Interventions
To evaluate the safety associated with the administration of [18F]BCPP-BF injection solution in healthy subjects and to estimate the radiation dose. In addition, we will evaluate changes in the distri
Sponsors
Bunai Tomoyasu
Harada Norihiro
Hamamatsu Photonics K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Between 40 and 80 years of age 2) Healthy individuals with no history or current medical history 3) Persons whose consent to participate in this study has been obtained by signing a consent form in person
Exclusion criteria
Exclusion criteria: 1) Those who need to take medication (whether on a regular or occasional basis) 2) Women who are pregnant or may become pregnant 3) Women who are breastfeeding 4) Patients with claustrophobia 5) Those with contraindications to MRI (pacemakers, metals in the body, tattoos, etc.) 6) Those who have participated in other studies using nuclear medicine examinations within one year of obtaining consent 7) Other subjects who are deemed inappropriate as research subjects by the principal Investigator or research supervisor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety associated with administration of [18F]BCPP-BF injection solution | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Estimated radiation dose associated with administration of [18F]BCPP-BF injection solution 2) Comparison of the whole-body distribution of [18F]BCPP-BF and [18F]BCPP-EF 3) MRI Examination: Evaluation of T1 structural MRI | — |
Contacts
Public ContactTomoyasu Bunai
Hamamatsu University Hospital
Outcome results
None listed